Rhinitis medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 18: | Line 18: | ||
|'''Severity of Rhinitis''' | |'''Severity of Rhinitis''' | ||
|'''Medication''' | |'''Medication''' | ||
* Use in conjunction with allergen avoidance and saline douching | |||
* Screen for undiagnosed asthma/evaluate control if asthmatic | |||
|'''Treatment Failure''' | |'''Treatment Failure''' | ||
(Ensure patient adherence to treatment before making changes to the treatment plan) | (Ensure patient adherence to treatment before making changes to the treatment plan) | ||
|- | |- | ||
|Mild | |Mild | ||
|Nonsedating oral/ | |Nonsedating oral/intranasal antihistamine | ||
|Consider intranasal steroids | |Consider intranasal steroids | ||
|- | |- | ||
|Moderate | |Moderate | ||
| | |Intranasal corticosteroid (+/- nonsedating oral or intranasal antihistamine) | ||
| | | rowspan="2" | | ||
* Increase dose +/- oral cortocosteroids | |||
|- | |||
|Severe | |||
|Intranasal corticosteroid (+/- nonsedating oral or intranasl antihistamine) | |||
|} | |} | ||
Revision as of 18:53, 24 January 2017
|
Rhinitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Rhinitis medical therapy On the Web |
|
American Roentgen Ray Society Images of Rhinitis medical therapy |
|
Risk calculators and risk factors for Rhinitis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fatimo Biobaku M.B.B.S [2]
Overview
Rhinitis is a heterogegeous disorder that is often undertreated or overlooked( PMID 11449200)
Treatment
The treatment of allergic rhinitis includes the following key components:[1][2][3]
- Patient education on allergen avoidance and non-pharmacologic treatments such as saline douching of the nose
- Pharmacotherapy
- Allergen-specific immunotherapy in patients uncontrolled with pharmacotherapy
- Surgery in selected cases
Pharmacotherapy
| Medical Treatment of Allergic Rhinitis | ||
|---|---|---|
| Severity of Rhinitis | Medication
|
Treatment Failure
(Ensure patient adherence to treatment before making changes to the treatment plan) |
| Mild | Nonsedating oral/intranasal antihistamine | Consider intranasal steroids |
| Moderate | Intranasal corticosteroid (+/- nonsedating oral or intranasal antihistamine) |
|
| Severe | Intranasal corticosteroid (+/- nonsedating oral or intranasl antihistamine) | |
References
- ↑ Lee S (2014). "Practical clinical approaches to the allergic rhinitis patient". Int Forum Allergy Rhinol. 4 Suppl 2: S66–9. doi:10.1002/alr.21389. PMID 25182359.
- ↑ Rotiroti, Giuseppina; Scadding, Glenis (July 2016). "Allergic Rhinitis-an overview of a common disease". Paediatrics and Child Health. Volume 26 (Issue 7): 298–303. Retrieved January 20, 2017.
- ↑ Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A; et al. (2008). "Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)". Allergy. 63 Suppl 86: 8–160. doi:10.1111/j.1398-9995.2007.01620.x. PMID 18331513.